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Alternatively activated brain-infiltrating
macrophages facilitate recovery from
collagenase-induced intracerebral
hemorrhage
Hyunjung Min1, Yong Ho Jang1, Ik-Hyun Cho2, Seong-Woon Yu3 and Sung Joong Lee1*
Abstract
Background: Intracerebral hemorrhage (ICH) is one of the major causes of stroke. After onset of ICH, massive
infiltration of macrophages is detected in the peri-hematoma regions. Still, the function of these macrophages in
ICH has not been completely elucidated.
Results: In a collagenase-induced ICH model, CX3CR1+ macrophages accumulated in the peri-hematoma region.
Characterization of these macrophages revealed expression of alternatively activated (M2) macrophage markers.
In the macrophage-depleted mice, ICH-induced brain lesion volume was larger and neurological deficits were
more severe compared to those of control mice, indicating a protective role of these macrophages in ICH. In the
ICH-injured brain, mannose receptor-expressing macrophages increased at a delayed time point after ICH,
indicating M2 polarization of the brain-infiltrating macrophages in the brain microenvironment. To explore this
possibility, bone marrow-derived macrophages (BMDM) were co-cultured with mouse brain glial cells and then
tested for activation phenotype. Upon co-culture with glia, the number of mannose receptor-positive M2
macrophages was significantly increased. Furthermore, treatment with glia-conditioned media increased the
number of BMDM of M2 phenotype.
Conclusions: In this study, our data suggest that brain-infiltrating macrophages after ICH are polarized to the M2
phenotype by brain glial cells and thereby contribute to recovery from ICH injury.
Keywords: Immune response, Macrophages, Wound healing
Background
Intracerebral hemorrhage (ICH) is a type of stroke char-
acterized by blood leakage into the brain parenchyma
due to blood vessel rupture within the brain. Although it
accounts for only about 15 to 20 % of all strokes, ICH
has a higher mortality and disability rate than other
types of stroke. In ICH, the initial insult due to the
mechanical force of the expanding hematoma and
plasma proteins is usually followed by secondary
damage, which involves inflammatory responses in the
peri-hematoma region [1, 2]. The inflammatory re-
sponses accompany brain-resident astrocyte activation,
compromise of the blood brain barrier (BBB) in the peri-
hematoma region, and recruitment of peripheral im-
mune cells such as neutrophils and macrophages to the
injury site [3–7]. We have previously reported that ICH-
induced neutrophil infiltration is partly responsible for
secondary brain damage after ICH [8]. Also, we have
shown that toll-like receptor 2 (TLR2)-mediated MMP9
activation in astrocytes is involved in the BBB comprom-
ise and subsequent neutrophil infiltration [8]. Other
literature has documented that brain-infiltrated neutro-
phils exert neurotoxic effects by producing reactive oxy-
gen species and pro-inflammatory mediators [9, 10].
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Although a detrimental role of brain-infiltrating neutro-
phils after ICH has been well-documented, the role of
brain-infiltrating macrophages has not been completely
elucidated.
It is well known that macrophages display plasticity in
their characteristics and can change phenotype and
functions depending on the microenvironment [11, 12].
Typically, stimulation with lipopolysaccharide (LPS)
and interferon-γ activates macrophages to express pro-
inflammatory mediators such as TNF-α and iNOS, re-
ferred to as “classically activated” M1 macrophages [13].
Conversely, interleukin (IL)-4 and IL-10 stimulation in-
duce “alternatively activated” M2 macrophages that pro-
mote tissue healing and angiogenesis [14]. These two
types of macrophage activations are detected in various
neurological injury models. In spinal cord injury, pro-
longed activation of M1 macrophages due to TNF-α and
iron impedes recovery after injury [15], while TLR2-
dependent M2 polarization of microglia protects against
spinal cord injury [16]. In a murine ischemic stroke model,
macrophages assume the M2 phenotype in early stages of
ischemic stroke but gradually transform into the M1
phenotype in the peri-infarct region, which exacerbates
neuronal death [17]. The phenotype of macrophages in
hemorrhagic stroke is not yet completely understood. In
this study, we used a mouse model of collagenase-induced
ICH to explore the function and phenotype of brain-
infiltrating macrophages after hemorrhagic stroke.
Methods
Animals
Cx3cr1+/GFP mice with GFP knocked into the gene
encoding CX3CR1 were from Jackson Laboratory.
Seven- to 11-week-old C57BL/6 mice were purchased
from Daehan Bio Link (Eumsung, Korea). All mice
were housed at 23 ± 2 °C with a 12 h light–dark cycle
and fed food and water ad libitum. All surgical and
experimental procedures were reviewed and approved
by the Institutional Animal Care and Use Committee
at Seoul National University.
ICH model
The procedure for inducing ICH through collagenase in-
jection in mice was adapted from a protocol previously
described [10]. Briefly, WT and Cx3cr1+/GFP mice (8–12-
week-old males, 22–25 g) were anesthetized using
Avertin (250 mg/kg body weight, i.p.) and placed on a
stereotaxic apparatus (myNeuroLab, St. Louis, MO,
USA). Animals were injected with PBS or collagenase
VII-S (0.075 U in 0.5 μl PBS; Sigma, St. Louis, MO,
USA) at a rate of 0.2 μl/min into the right caudate
putamen (stereotaxic coordinates in millimeters with
reference to bregma: AP, −0.9; ML, +2.8; DV, −4.0) using
a 26-G needle. After 5 min, the needle was removed in
three intermediate steps for 3 min to minimize backflow.
The incision was disinfected with povidone iodide solu-
tion and sutured, and the animals were kept on a warm
pad during recovery.
Injury volume analysis
To prepare brain tissue sections, animals were deeply
anesthetized with urethane and perfused intra-cardially
with saline followed by cold 4 % paraformaldehyde
(PFA) in a 0.1 M phosphate buffer. The brains were
removed, post-fixed overnight in the same fixative at
4 °C, rinsed twice with PBS, and placed serially in 10,
20, and 30 % sucrose in PBS for 72 h at 4 °C. The
brains were then quickly frozen and cut into serial
coronal sections (50 μm thickness) in a cryostat
(CM3050S, Leica, Germany). Sections were collected
as free-floating sections in cold PBS and then used
for histological analysis. Five coronal brain slices from
different levels of the injured hemorrhagic area were
selected from each mouse brain and used for cresyl
violet staining. The injury area was quantified using
Image J software (National Institutes of Health, Bethesda,
MD, USA), and the injury volume was calculated in cubic
millimeters (mm3) by multiplying section thickness by
measured injury area.
Behavioral test
The adhesive removal test (ART) was performed as pre-
viously described [18]. Mice were habituated for at least
30 min prior to applying the sticky tape on the sole of
the left fore paw. The removal time was defined as the
period from the mouse’s initial reaction to the presence
of the adhesive tape strips to the time it detached the
tape using its mouth or forelimb. The duration of the
procedure to test one mouse was 300 s maximum. ART
was performed at 1 and 3 days after ICH or sham oper-
ation. Neurological function was measured by scoring
focal deficits on a 28-point neurological scoring system
[19]. Habituated mice were scored on the following mea-
sures: (1) Body symmetry, (2) Gait, (3) Climbing, (4)
Circling behavior, (5) Front limb symmetry, (6) Compul-
sory circling, and (7) Whisker response. One and 3 days
after ICH, scoring was performed on each subject on a
scale from 0 to 4, and the scores were averaged.
Peripheral macrophage/monocyte depletion
Peripheral monocytes/macrophages were systemically
depleted using a clodronate liposome suspension
(ClodronateLiposome.com, Amsterdam, Netherlands).
Mice were injected intra-peritoneally with 1 mg of
clodronate liposome (Cl2MDP) or saline 1 day before
ICH surgery. One day after ICH, an additional injec-
tion was administered in order to increase the deple-
tion rate. To measure depletion efficiency, the brains
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and blood samples were collected and monocyte/
macrophage populations were evaluated by flow cytome-
try or anti-CD68 immunofluorescence staining.
Immunohistochemistry
Immunostaining was carried out using previously
established protocols [20]. The sections were incu-
bated in a blocking solution (5 % normal donkey
serum, 2 % BSA, and 0.1 % Triton X-100) for 1 h at
room temperature (RT). The sections were then incu-
bated overnight at 4 °C with goat anti-Arginase-1
(1:50; Santa Cruz Biotechnology, CA, USA) and rat
anti-CD68 (1:100; AbD Serotec, Oxford, UK). The
sections were incubated for 1 h at RT with Cy3-
conjugated secondary antibodies (1:200; Jackson
ImmunoResearch, West Grove, PA, USA) and then
mounted on gelatin-coated slides and cover-slipped
with VectaShield medium (Vector Labs, Burlingame,
CA, USA). All images were acquired using confocal
laser scanning microscopy (LSM700; Carl Zeiss,
Germany).
Quantitative real-time RT-PCR
The cDNA was synthesized using total RNA from
mouse brain tissue or in vitro cultured cells. The reverse
transcription mixture consisted of 1–3 μg of total RNA,
oligo-dT, M-MLV, RNAse inhibitor, DTT, and RT buffer
and was synthesized at 37 °C for 1 h. Real-time RT-PCR
was performed using SYBR Green PCR Master Mix
(ABI, Waltham, MA, USA) as previously described [20].
Reactions were performed in duplicate in a total volume
of 12 μl containing 10 pM primer, 5 μl cDNA, and 6 μl
SYBR Green PCR Master Mix (ABI). The mRNA level
of each target gene was normalized to that of GAPDH
mRNA. Fold-induction was calculated using the 2-ΔΔCT
method, as previously described [21]. All real-time
RT-PCR experiments were performed at least three
times and are presented as mean ± SEM unless other-
wise noted. The following sequences of primers were
used for real-time RT-PCR: Arginase-1 forward: 5′-G
GG CTC TGA TGA GAA GGA GA-3′; Arginase-1
reverse: 5′-GTA GAT GCC ACG CTG GTA CA-3′;
Ym1 forward: 5′-GAA GGA GCC ACT GAG GTC
TG-3′; Ym1 reverse: 5′-CAC GGC ACC TCC TAA
ATT GT-3′; iNOS forward: 5′-GGC AAA CCC AAG
GTC TAC GTT-3′; iNOS reverse: 5′-TCG CTC AAG
TTC AGC TTG GT-3′; TNF-α forward: 5′-AGC
AAA CCA CCA AGT GGA GGA-3′; TNF-α reverse:
5′-GCT GGC ACC ACT AGT TGG TTG T-3′;
CD16 forward: 5′- TTT GGA CAC CCA GAT GTT
TCA G-3′; CD16 reverse: 5′ GTC TTC CTT GAG
CAC CTG GAT C-3′; CD86 forward: 5′- TTG TGT
GTG TTC TGG AAA CGG AG-3′ and CD86 reverse:
5′- AAC TTA GAG GCT GTG TTG CTG GG-3′.
Primary mouse brain glial cell culture
Primary mouse brain glial cultures were prepared as
previously described [22]. Briefly, brains were pre-
pared from postnatal day 1–3 wild-type mice. After
removing the meninges from the cerebral hemisphere,
tissue was dissociated into a single-cell suspension
through gentle repetitive pipetting. Cells were cultured
in Dulbecco’s Modified Eagle’s medium (DMEM) and
supplemented with 10 mM HEPES, 10 % FBS,
2 mM L-glutamine, 1X non-essential amino acids
(NEAA), and 1X antibiotic/antimycotic in 75 cm2
flasks at 37 °C in a 5 % CO2 incubator. The medium
was changed every 5 days.
BMDM culture
The protocols for BMDM culture and cryopreserva-
tion were adapted from a previous study [23]. Briefly,
femurs and tibias were obtained from 8 to 12-week-
old C57BL/6 or Cx3cr1+/GFP mice. The bones were
flushed with a syringe filled with DMEM to extrude
bone marrow into a 50 ml sterile tube. The cells were
gently homogenized using a plastic pipette and ali-
quoted in freezing media containing 90 % FBS and
10 % DMSO. The aliquots were maintained at −80 °C
for 24 h and then transferred to a liquid nitrogen
tank. Bone marrow cells were thawed, washed with
warm-DMEM, and then cultured in DMEM supple-
mented with 10 mM HEPES, 10 % FBS, 2 mM L-glutam-
ine, 1X NEAA, 1X antibiotic/antimycotic, and 30 ng/ml
recombinant human macrophage colony stimulating
factor (rhM-CSF; Peprotech, Rocky Hill, NJ, USA) at
37 °C in a 5 % CO2 atmosphere for 5 days. For
mRNA quantification or flow cytometry analysis,
BMDMs were seeded in a 6-well plate (2.5–5 × 105/
well) with growth media supplemented with 10 ng/ml
rhM-CSF for 2 days.
Co-culture experiment
While the BMDM were removed from the plate with
a scraper, the primary mixed glial cells were simultan-
eously detached using trypsin. Cells were counted
using a hemocytometer (2.5–5 × 105 cells) and then
added to a 60 mm culture dish at a 1:1 ratio in
BMDM growth medium-containing 10 ng/ml rhM-
CSF. Co-cultures were incubated at 37 °C in a CO2
incubator.
Glial cell-conditioned media treatment
Two weeks after glial culture, conditioned media were
collected. To prevent cell contamination, conditioned
media were centrifuged for a short time and then
stored in a −80 °C deep freezer. A 1:1 mixture of
glia-conditioned media and BMDM growth media was
used for treatment.
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Flow cytometry
The mice were deeply anesthetized with urethane and
intra-cardially perfused with ice-cold saline. Ipsilateral
hemispheres were trimmed on the anterior and posterior
sides from the needle hole, and then residues of brain
hemispheres were homogenized mechanically to a single
cell-suspension. In addition, blood samples were col-
lected by retrobulbar puncture before mice were per-
fused with saline and red blood cells were removed by
RBC lysis buffer (150 mM NH4Cl, 10 mM KHCO3,
100 μM EDTA). For the analysis of cultured cells, co-
cultures or BMDMs were removed from the plates with
cold PBS and re-suspended using a pipette. Cells were
washed with ice-cold 2 % FBS in PBS and incubated with
Fc BlockerTM (BD Bioscience, San Jose, CA) for 10 min
at 4 °C prior to staining with CD11b-FITC, CD45-PE,
CD206-APC, F4/80-PE/Cy7 (Biolegend Inc., San Diego,
CA). BD FACSCalibur flow cytometer (BD Bioscience)
was used to measure the microglia as CD11b+/CD45low,
peripheral macrophage as CD11b+/CD45high, and
BMDM as CD45+/GFP+ or CD11b+/CD45+. Data were
acquired and analyzed with BD CellQuestTMsystem (BD
Biosciences).
Statistical analysis
Statistically significant differences between two groups
were determined using two-tailed Student’s t-test. Differ-
ences among multiple groups were identified using one-
way ANOVA followed by Bonferroni correction. All data
are presented as mean ± SEM, and differences were con-
sidered significant when the p-value was less than 0.05.
Results
ICH injury induces macrophage infiltration into injured
brain parenchyma
To detect macrophages infiltrating brain parenchyma
after ICH injury, we utilized Cx3cr1+/GFP mice in which
CX3CR1-expressing macrophages and microglia can be
monitored using GFP fluorescence. Following ICH, the
cells with GFP fluorescence increased as soon as 1 day
post-injury (dpi) in the surrounding area of hematoma,
indicating upregulation of CX3CR1 in microglia/macro-
phages in this area (Fig. 1b and c). Three days after ICH,
CX3CR1+ cells greatly increased in the injured brain
area. In particular, round CX3CR1+ cells, morphologic-
ally presumed to be brain-infiltrating activated macro-
phages, accumulated in the peri-hematoma region,
which was further increased on 7 dpi (Fig. 1d and e). To
differentiate macrophages from microglia in this
CX3CR1+ population, we analyzed the F4/80-positive
monocytic cell population in the injured brain using flow
cytometry based on the expression level of CD45 (Fig. 1f )
[24]. The percentage of CD45high/F4/80+ leukocytes
representing the macrophage population increased to
11.5 % on 1 dpi and 31 % on 3 dpi from 1.8 % (sham).
In the same time frame, the number of CD45low/F4/80+
cells representing the microglia population was not as
significantly altered; it increased only to 58 % on 3 dpi
from 40 % (sham). These data demonstrate that the
increase in CX3CR1+ cells after ICH is mainly due
to macrophage infiltration rather than microglia
proliferation.
Brain-infiltrating macrophages following ICH show M2
phenotype
To characterize the phenotype of the brain-infiltrating
macrophages, we analyzed expression of typical M1
(CD16, CD86, and iNOS) and M2 (Arginase-1 and Ym1)
markers in the injured brain. Upon initiation of ICH, the
mRNA expression of Arginase-1 increased more than
300-fold in the injured brain at 7 dpi. Likewise, Ym1, an-
other M2 marker, expression was increased 15-fold at 3
dpi (Fig. 2a and b). For M1 markers, only CD16 expres-
sion was increased 4.7-fold at 3 dpi (Fig. 2c), whereas
other M1 markers such as CD86 and iNOS expressions
were not significantly altered (Fig. 2d and e). Arginase-1
expression was mainly detected in CX3CR1+ macro-
phages/microglia in the peri-hematoma region (Fig. 2f,
arrows), suggesting that macrophages/microglia in the
injured brain are polarized to the M2 phenotype. To
confirm these data, we analyzed the expression of man-
nose receptor (CD206), another M2 marker, in the
CD11b+ monocyte cell population in the ipsilateral ICH-
injured brain using flow cytometry (Fig. 2g). The per-
centages of mannose receptor-expressing macrophages
(CD206+/CD11b+/CD45high) increased to 68.5 % at 7 days
post-ICH, whereas the CD206+ microglia population
(CD206+/CD11b+/CD45low) increased to only 16.7 %.
Taken together, these data suggest that the majority of
macrophages in the ICH-injured brain are polarized to the
M2 phenotype at delayed time points (3 and 7 dpi).
Macrophage depletion attenuates recovery after ICH
To assess the role of these M2 macrophages, we
depleted the monocyte cell population by treating
with clodronate liposome (Cl2MDP) and then sub-
jected mice to ICH injury. Upon Cl2MDP injection
(i.p.), 97 % of blood monocytes were depleted from
the blood (Fig. 3b). In the ICH-injured brain, the
percentage of CD11b+/CD45high macrophages was
increased to 8.1 % (saline-ICH) from 1.5 % (saline-
sham) (Fig. 3c). However, in the Cl2MDP-treated mice
brain, the macrophage population only increased to 1.6 %
(Cl2MDP-ICH) from 0.9 % (Cl2MDP-sham). Meanwhile,
the microglia (CD11b+/CD45low) populations were not
significantly altered by Cl2MDP treatment (Fig. 3c).
Decreased macrophage infiltration in the Cl2MDP-
injected mouse brain was also confirmed by
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immunohistochemistry (Fig. 3d). The CD68+ macro-
phages in the ICH-injured brain were significantly re-
duced in Cl2MDP-treated mice (Fig. 3d). Cresyl violet
staining of ipsilateral brain sections from Cl2MDP- or
saline-treated mice showed that monocyte-depleted
mice had larger infarct volumes after ICH compared
to control mice (Fig. 3e and f ). Consistent with the
histological data, the Cl2MDP-treated mice displayed
more severe motor function impairment as measured
by the adhesive removal test (Fig. 3g) and focal defi-
cits scoring (Fig. 3h) at 3 dpi. These findings indicate
that brain-infiltrating M2 macrophages play a protect-
ive role by presumably facilitating recovery from ICH
injury.
Macrophages are polarized to M2 phenotype by soluble
factors secreted by glial cells
Since the macrophages in the injured brain were M2
phenotype, it is conceivable that brain microenviron-
ment polarizes brain-infiltrating macrophages to the M2
phenotype. Supporting this possibility, a previous study
has shown that bone marrow-derived macrophages
(BMDM) exhibit an M2-like phenotype after co-culture
with an astroglioma cell line [25]. To test if glial cells
affect macrophage polarization toward the M2 pheno-
type, BMDM from Cx3cr1+/GFP mice were co-cultured
with primary cultured mouse brain glial cells, and man-
nose receptor expression was measured using flow cy-
tometry. After co-culture with primary glia for 3 days,
the percentage of CD206+ cells in the BMDM popula-
tion (GFP+/CD45+) increased to 20 %, indicating
polarization to the M2 phenotype (Fig. 4a and b). Not-
ably, the percentage of CD206+ BMDM also increased to
more than 60 % upon incubation in glia-conditioned
media for 3 days (Fig. 4c), indicating that direct cell con-
tact between BMDM and glia is not required for M2
polarization. In addition, the expression of other M2
genes Arginase-1 and Ym1 increased by 1.5- and 6-fold,
respectively (Fig. 4d and e). However, expression of
iNOS and TNF-α mRNA, M1 marker genes, was not
Fig. 1 CX3CR1+ cells increase in the peri-hematoma region after ICH. a CX3CR1+ cells were detected in peri-hematoma regions of hemorrhagic
brain sections. b–e Representative images on brain sections were obtained from Cx3cr1+/GFP mice at 1, 3, and 7 days after ICH or sham operation.
Three days after ICH, amoeboid cells were detected in the peri-hematoma region (arrows) (Scale bar, 100 μm). f Myeloid cells (F4/80+) in the
lesion were analyzed and further divided into CD45-low microglia and CD45-high macrophage populations according to the expression level of
CD45 according to flow cytometry. The flow cytometry data are representative of three independent experiments
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significantly upregulated after glia-conditioned media
treatment (Fig. 4f and g). These data suggest that glia-
derived soluble factor(s) induce M2 polarization of the
BMDM, which might account for the M2 polarization of
macrophages observed in the ICH-injured brain.
Discussion
Although the function of brain-infiltrating immune cells
in ischemic stroke has been well documented, their role
in hemorrhagic stroke is not completely understood. To
our knowledge, this study is the first to assert that mac-
rophages infiltrating brain parenchyma after ICH might
play a beneficial role in recovery from ICH injury. Our
data are in contrast to the recent report by Hammond et
al., which showed that brain-recruited inflammatory
monocytes exacerbate disability following ICH [26]. In
this study, they showed that immune cells recruited to
the injured brain after ICH are mainly CCR2+/Ly6C+ in-
flammatory macrophages that peaked at 1–3 dpi. Such
discrepancy might simply be due to differences in their
injury model, since they characterized the phenotype of
macrophages in an ICH model using autologous blood
infusion. They also showed that these inflammatory
macrophages contribute to acute neurological deficit
by depleting inflammatory macrophages using CCR2
antibody. CCR2 is expressed on inflammatory macro-
phages but not on CX3CR1+ monocytes [27]. Thus,
the treatment of this antibody might have depleted
only inflammatory monocytes but not CCR2-negtive
M2 macrophages. Therefore, it is possible that the
contribution of anti-inflammatory or wound-healing
M2 macrophages that are recruited after 3 dpi might
have been overlooked in their study.
It should also be noted that clodronate liposome may
deplete both monocytes and other myeloid cells, such as
dendritic cells. A recent study showed that dendritic
cells were also recruited to the injured brain after ICH
[28]. Thus, we cannot rule out the possibility that the ef-
fects of clodronate liposome on ICH injury could be due
to both monocyte and dendritic cell depletion. In the
present study, we did not analyze the relative contribu-
tions of brain-infiltrating macrophages and dendritic
cells, which warrants future investigation.
Our data clearly show that brain-infiltrating macro-
phages play distinct roles depending on the stroke model
used. In a murine ischemic stroke model, macrophages
played a detrimental role by exacerbating neuronal cell
death [17]. In this model, macrophages in the peri-
infarct brain region were gradually transformed into M1
phenotype, which contributed to the detrimental effects
Fig. 2 M2 macrophages are increased in the ipsilateral brain after ICH. a-e mRNA expressions of M2 markers (Arg-1 and Ym1) or M1 markers
(CD16, CD86 and iNOS) in the ICH mice brains were measured using real-time RT-PCR. Total RNA was isolated from ipsilateral hemorrhagic tissue
and used for quantitative real-time RT-PCR (n = 3 per group, **p < 0.01, ***p < 0.001). f Representative images of Arg-1 immunofluorescence (red)
in the CX3CR1+/GFP mice brain sections obtained from ICH or sham-control mice. Arg-1 immunofluorescence merged with myeloid cell-specific
GFP signals is denoted (arrows) (Scale bar, 100 μm). g Dissociated cells from the injured tissue were obtained 1, 3, and 7 days after ICH injury and
were used for flow cytometry with anti-CD11b-FITC, −CD45-PE, and -CD206-APC antibodies. Representative flow cytometry histograms show
CD206+ cells gated on CD11b+/CD45+ populations. The flow cytometry data are representative of three independent experiments
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[17]. In collagenase-induced ICH, M2 phenotype macro-
phages expressing Arginase-1, Ym1 and CD206 were ob-
tained at delayed time points (3 and 7 dpi). Thus far, it
is not clear why macrophages are activated differently
depending on the stroke model. Although purely specu-
lative, it is presumed that the microenvironment of the
ischemic-injured brain might be distinct from that of
the hemorrhagic brain. In this regard, it is of note
that ischemic neurons are able to prime microglia
polarization to M1 phenotype [17].
In this study, we did not elucidate how M2 macro-
phages exert their neuroprotective effects in ICH. It is
well-known that M2 polarized macrophages contribute
to wound-healing by producing various wound-repair
genes [29]. It has been reported that brain-infiltrating
macrophages contribute to damaged neurovascular unit
Fig. 3 Depletion of peripheral monocytes in ICH injury. a Schematic diagram of the myeloid cell depletion protocols using Cl2MDP. b Blood cells
obtained from saline (black line)- or Cl2MDP-treated ICH mice (gray line) were stained with anti-CD11b-FITC antibody and analyzed with flow
cytometry. c Cell suspensions obtained from saline- or Cl2MDP-treated mouse brain were stained with anti-CD11b-FITC and anti-CD45-PE antibody
and analyzed with flow cytometry. Representative flow cytometry dot plots are shown. d ICH injured brain sections were collected and stained with
anti-CD68 antibody. Representative images of three independent experiments are shown (Scale bar, 50 μm). e One day after Cl2MDP injection, mice
were subjected to ICH, and the brains were sectioned and stained with cresyl violet at 3 dpi. Representative pictures are shown (Scale bar, 1 mm).
f Hemorrhagic injured volumes were quantified and presented in a graph (n = 4 per group, *p < 0.05). g, h After Cl2MDP or saline i.p. injection, mice
were subjected to ICH, and neurological outcomes were evaluated by focal deficit and sticky tape removal time at 1 and 3 days after ICH (n = 5 for
saline and Cl2MDP groups in ART; n = 4 for saline group, n = 3 for Cl2MDP group in focal deficit, *p < 0.05). Data are expressed
as mean ± SEM
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repair through TGF-β1 secretion [30]. Therefore, it is
possible that brain-infiltrating M2 macrophages reduce
infarct damage by contributing to the wound-healing
process in the injured brain tissue. In addition, studies
have shown that M2 polarized microglia protect neurons
by secreting neurotrophic factors such as BDNF or IGF
[31, 32]. In this regard, it is also conceivable that M2
macrophages protect neurons from ICH injury by pro-
ducing such neurotrophic factors.
In our effort to elucidate mechanisms of macrophage
M2 polarization in the ICH brain, we found that glia-
derived soluble factors have a tendency to drive M2
polarization of BMDM. After infiltration into inflamed
tissue, the phenotype and activation of macrophages can
be dynamically changed by the microenvironment of the
recruiting tissue [33, 34]. In ICH-injured brains, brain-
infiltrating macrophages most likely encounter a brain
microenvironment consisting of glial cells in the peri-
hematoma region [35, 36]. Because a co-culture system
is widely accepted to study the influence of tissue micro-
environment on macrophages, we postulated that a
mixed glia culture in vitro might recapitulate the brain
microenvironment of brain-infiltrating macrophages
during ICH, and tested macrophage polarization in co-
culture with mixed glia. Indeed, our data showed that
primary glial cell-conditioned media can induce the
macrophage M2 phenotype. These data are in line with
a previous document showing that astrocytes can induce
M2 activation of BMDM via the upregulation of miR-
124 [25]. In addition to the glia-derived factors, various
neuron-derived factors are implicated in driving the
macrophage M2 phenotype, including CX3CL1 and frag-
mented myelin [37, 38]. In this regards, we do not ex-
clude the possibility that macrophages are polarized to
M2 phenotype due to neuron-derived molecules in the
ICH-injured brain. Although we have not clearly demon-
strated the mechanism, our data suggest that brain-
infiltrating macrophages are polarized to the M2 pheno-
type due to the microenvironment of the ICH-injured
brain, which facilitates recovery from ICH injury.
Conclusions
In this study, we found that alternatively activated (M2)
macrophages accumulate in the ICH-injured brain.
These macrophages contribute to recovery from ICH at
a delayed time. Additionally, we showed that soluble fac-
tors released from glial cells drive macrophages to the
M2 phenotype. Our data suggest that brain-infiltrating
macrophages are polarized to the M2 phenotype and fa-
cilitate recovery after ICH.
Fig. 4 Soluble factors from mouse brain glial cells induce M2 polarization of BMDM. a BMDM from Cx3cr1+/GFP mice were cultured with or
without primary glial cells from C57BL/6 mice in a 1:1 ratio for 1 or 3 days. Then the expression of CD206 (a M2 marker) was analyzed using flow
cytometry. Representative histograms of CD206 expression in GFP+/CD45+ populations are shown. b The percentages of CD206+ populations in
BMDM were calculated. Mean ± SEM of 3 independent experiments are shown (*p < 0.05). c BMDM were incubated in primary glia-conditioned
media for 1 and 3 days. Then, the cells were harvested and stained with CD45-PE, CD11b-FITC, and CD206-APC for flow cytometry analysis. The
percentages of CD206+ cells in CD45+/CD11b+ populations are analyzed. Mean ± SEM of 3 independent experiments are shown (*p < 0.05,
***p < 0.001). d–g Total RNA was isolated from BMDM at 1 or 3 days after glia-conditioned media treatment. Arg-1, Ym1, iNOS, and TNF-α mRNA
expressions were measured using real-time RT-PCR. Mean ± SEM of at least 3 independent experiments are shown (*p < 0.05)
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